PHV02 (rVSV-Nipah virus vaccine candidate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PHV02 (rVSV-Nipah virus vaccine candidate), covering 2025-06-08 to 2025-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects [Phase 1]